J J C Sidrim, L V Perdigão-Neto, R A Cordeiro, R S N Brilhante, J J G Leite, C E C Teixeira, A J Monteiro, R M F Freitas, J F Ribeiro, J R L Mesquita, M V F Gonçalves, M F G Rocha
Index: Can. J. Microbiol. 58(7) , 932-6, (2012)
Full Text: HTML
The effects of the protease inhibitors saquinavir, darunavir, ritonavir, and indinavir on growth inhibition, protease and phospholipase activities, as well as capsule thickness of Cryptococcus neoformans were investigated. Viral protease inhibitors did not reduce fungal growth when tested in concentrations ranging from 0.001 to 1.000 mg/L. A tendency toward increasing phospholipase activity was observed with the highest tested drug concentration in a strain-specific pattern. However, these drugs reduced protease activity as well as capsule production. Our results confirm a previous finding that antiretroviral drugs affect the production of important virulence factors of C. neoformans.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Saquinavir mesylate
CAS:149845-06-7 |
C39H54N6O8S |
Intranasal in situ gel loaded with saquinavir mesylate nanos...
2014-11-20 [Int. J. Pharm. 475(1-2) , 191-7, (2014)] |
Saquinavir-NO-targeted S6 protein mediates sensitivity of an...
2012-03-15 [Cell Cycle 11(6) , 1174-82, (2012)] |
Can inhibition of proteasomes or NF-kappaB help control idio...
2012-05-01 [Nephrol. Dial. Transplant. 27(5) , 1698-701, (2012)] |
Saquinavir-NO inhibits S6 kinase activity, impairs secretion...
2013-06-15 [J. Neuroimmunol. 259(1-2) , 55-65, (2013)] |
Stereoselective evasion of P-glycoprotein, cytochrome P450 3...
2012-09-01 [J. Pharm. Sci. 101(9) , 3199-213, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved